v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:            
Net income $ 3,737 $ 2,883 $ 3,468 $ 3,981 $ (2,687) $ 4,776
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities            
Depreciation and amortization 926 941 1,380 1,438 1,553 1,827
Amortization of operating lease assets 310 256 415 433 545 875
Provision for expected credit losses 89 38 133 138 128 88
Deferred income tax expense/(benefit) 1,349 2,218 4,577 (638) (1,500) 1,258
Share based compensation 256 134 107 217 137 297
(Gain) loss on disposal of business (5,746) 0 (4,786)   (2,536) 408
Changes in operating assets and liabilities, net of business disposals:            
Accounts receivable (6,199) 2,525 (2,276) (1,978) (2,089) 246
Prepaid expenses and other assets 171 (2,142) 408 (1,630) 416 (1,350)
Accounts payable 2,493 (552) 4,333 684 7,459 (2,010)
Operating lease liabilities (310) (256) (415) (433) (541) (875)
Accrued expenses, other current liabilities and customer incentives and deposits 1,213 427 (7,648) (1,522) (1,124) (1,919)
Net cash (used in) provided by operating activities of continuing operations 596 6,472 (304) 690 (239) 3,621
Net cash (used in) provided by operating activities of discontinued operations (426) 272 (426) 950 (426) 3,200
Net cash (used in) provided by operating activities 170 6,744 (730) 1,640 (665) 6,821
Cash flows from investing activities:            
Proceeds from sale of joint ventures, net of cash transferred         7,259 (1,067)
Purchases of property and equipment and internal use software (771) (694) (898) (1,037) (1,129) (1,194)
Net cash provided by (used in) investing activities of continuing operations 7,211 (694) 5,777 (1,037) 6,130 (2,261)
Net cash provided by (used in) investing activities of discontinued operations 3,751 (23) 3,751 (46) 3,751 (8)
Net cash provided by (used in) investing activities 10,962 (717) 9,528 (1,083) 9,881 (2,269)
Cash flows from financing activities:            
Borrowings under lines of credit 69,117 47,340 103,184 80,151 132,133 103,742
Repayments under lines of credit (64,044) (50,003) (97,782) (79,520) (128,347) (104,845)
Payment of notes to seller (1,843)   (1,843)   (1,843) 0
Repurchase of common stock (1,800)   (1,800)   (1,800) 0
Distribution to non-controlling investors 0 0 0 (427) 0 (426)
Payments to acquire noncontrolling interests (250)   (250) (473) (500) (473)
Proceeds from long-term debt         15 930
Payments on term debt         0 (701)
Net cash used in financing activities of continuing operations 1,206 (3,136) 1,525 (269) (341) (1,773)
Net cash used in financing activities of discontinued operations (1,315) (1,196) (1,315) (1,247) (1,315) (1,247)
Net cash used in financing activities (109) (4,332) 210 (1,516) (1,656) (3,020)
Effect of foreign exchange rate changes on cash (48) (124) (75) (426) (58) (158)
Net increase in cash and cash equivalents 10,976 1,571 8,933 (1,385) 7,502 1,374
Cash and cash equivalents at beginning of year 10,719 9,345 10,719 9,345 10,719 9,345
Cash and cash equivalents at end of year $ 21,695   $ 19,652   18,221 10,719
Less cash and cash equivalents of discontinued operations   1,815   3,081 0 6,228
Cash and cash equivalents from continuing operations   $ 9,101   $ 4,879 18,221 4,491
Supplemental disclosure of cash flows information            
Interest paid         2,059 2,331
Income taxes paid         277 1,585
Promissory notes issued to Resource Plus non-controlling interest         $ 2,500 $ 0